Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...

The global injection pen market is expanding at a fast rate with the growing prevalence of chronic diseases, and increasing demand for convenient self-administration options. This trend is a move ...

The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...

Nearly one-third of those patients were paying $35 or far more per month in 2019, according to the latest available data from ...

Last spring, Eli Lilly reported its drugs Humalog and insulin lispro were in short supply ... products and more than 800 million insulin pens a year. "Not only are we not winding down our work ...